These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 16272650

  • 1. [Clinical significance of PTH (1-84) and PTH (7-84) in patients with predialysis chronic renal failure in relation to bone metabolism markers].
    Tsuchida T, Ishimura E, Hirowatari K, Matsumoto N, Jono S, Miki T, Inaba M, Nishizawa Y.
    Clin Calcium; 2005 Sep; 15 Suppl 1():156-60; discussion 160. PubMed ID: 16272650
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy.
    Kato Y, Yamaguchi S, Yachiku S, Fujisawa M, Kawakami N.
    Hinyokika Kiyo; 2004 Nov; 50(11):755-62. PubMed ID: 15628534
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A, Olusi S, Al-Zaid N, Prabha K.
    J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An automated 'bio-intact' PTH assay: a step towards standardisation and improved correlation with parathyroid function in renal disease.
    Savoca R, Bock A, Kraenzlin ME, Schmid HR, Huber AR.
    Clin Chim Acta; 2004 May; 343(1-2):167-71. PubMed ID: 15115690
    [Abstract] [Full Text] [Related]

  • 8. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
    Singh AK, Avula S, Kher V, Rao DS, Mithal A.
    Natl Med J India; 1999 May; 12(5):202-7. PubMed ID: 10612998
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of serum beta-carboxy-terminal cross-linking telopeptide of type I collagen as marker of bone resorption in chronic hemodialysis patients.
    Reichel H, Roth HJ, Schmidt-Gayk H.
    Nephron Clin Pract; 2004 May; 98(4):c112-8. PubMed ID: 15627788
    [Abstract] [Full Text] [Related]

  • 10. PICP as bone formation and NTx as bone resorption marker in patients with chronic renal failure.
    Franke S, Lehmann G, Abendroth K, Hein G, Stein G.
    Eur J Med Res; 1998 Feb 21; 3(1-2):81-8. PubMed ID: 9512973
    [Abstract] [Full Text] [Related]

  • 11. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
    Inaba M, Okuno S, Imanishi Y, Ueda M, Yamakawa T, Ishimura E, Nishizawa Y.
    Osteoporos Int; 2005 May 21; 16(5):517-25. PubMed ID: 15322741
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
    Tsuchida T, Ishimura E, Miki T, Matsumoto N, Naka H, Jono S, Inaba M, Nishizawa Y.
    Osteoporos Int; 2005 Feb 21; 16(2):172-9. PubMed ID: 15164161
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 21; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.